'Absent or trivial' effects: Anti-amyloid Alzheimer's drugs called into question once again
'Absent or trivial' effects: Anti-amyloid Alzheimer's drugs called into question once again
'Absent or trivial' effects: Anti-amyloid Alzheimer's drugs called into question once again
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.